TMDI - チタン・メディカル (Titan Medical Inc.)


   Titan Medical receives Nasdaq notice, requests hearing (NASDAQ:TMDI)  2022/12/29 07:12:02 Seeking Alpha
Titan Medical (TMDI) received Nasdaq notice for non-compliance as it does not meet the minimum bid price requirement set forth in Nasdaq as of December 26, 2022.The company plans to…
   Titan Medical Announces Receipt of Nasdaq Listing  2022/12/28 22:01:00
TORONTO, ON, Dec. 28, 2022 (GLOBE NEWSWIRE) — Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD) (the “Company”), a medical device company focused on the development and commercialization of innovative surgical […] The post Titan Medical Announces Receipt of Nasdaq Listing appeared first on Businessfortnight .
   Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday''s Mid-Day Session  2022/12/07 18:45:59 Benzinga
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX ) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint. TransCode Therapeutics, Inc. (NASDAQ: RNAZ ) shares climbed 59.1% to $0.6679 after the company reported withdrawal of registration statement. BioVie Inc. (NASDAQ: BIVI ) gained 26.2% to $5.87. BioVie recently announced results from two Phase 2 trials assessing NE3107''s potential in Parkinson''s Disease (PD) and Alzheimer''s Disease (AD). Bit Brother Limited (NASDAQ: BTB ) climbed 23.1% to $0.4680. Vor Biopharma Inc. (NASDAQ: VOR ) climbed 21.4% to $5.22 after the company disclosed initial clinical data from VBP101, its Phase 1/2a multicenter, open-label, first-in-human study of tremtelectogene empogeditemcel or “trem-cel” (formerly VOR33) in patients with acute myeloid leukemia. Vor Bio also priced underwritten offering of 15.3 million shares of common stock at $4.30 per share.
   AI-based Surgical Robots Global Market Report 2022: Ukraine-Russia War Impact  2022/11/23 13:00:00 PR Newswire
NEW YORK, Nov. 23, 2022 /PRNewswire/ -- Major players in the ai-based surgical robots market are Accuray Incorporated, Intuitive Surgical Inc, Medtronic plc, Medrobotics Corporation, Zimmer Biomet, Stereotaxis Inc, TransEnterix Inc , Stryker Corporation, Activ Surgical Inc, Titan Medical…
   Titan Medical Inc. (TMDI) Q3 2022 Earnings Call Transcript  2022/11/10 17:59:12 Seeking Alpha
Titan Medical Inc. (NASDAQ:NASDAQ:TMDI) Q3 2022 Earnings Conference Call November 10, 2022, 8:30 AM ET Company Participants Kristen Galfetti - VP of IR Cary Vance - President & CEO…
   Titan Medical appoints CEO  2022/06/30 20:08:36 Seeking Alpha
Medical device company Titan Medical (TITXF) appointed Cary Vance president and CEO, effective Jul. 1.
   Titan Medical granted 180-day extension to regain compliance with Nasdaq''s minimum bid price rule  2022/06/29 14:51:23 Seeking Alpha
Titan Medical (TMDI) has been granted an additional 180 calendar day period, through December 26, 2022, to evidence compliance with the US$1.00 minimum bid price requirement for…
   Titan teams up with Nissha Medical to advance Enos surgical system  2022/06/21 13:32:24 Seeking Alpha
MedTech company Titan Medical (TMDI) announced a partnership with New York-based medical device company Nissha Medical Technologies to produce surgical consumables targeting…
   Titan Medical Reports Voting Results From Annual and Special Meeting of Shareholders  2022/06/09 22:57:57 Benzinga
TORONTO, June 09, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. ((Nasdaq: TMDI, TSX: TMD ), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced the voting results form the company''s Annual and Special Meeting of its shareholders held on Wednesday June 8, 2022. All of management''s nominees for election were duly elected as directors of the company by the shareholders presented or represented by proxy at the meeting. A total of 54,760,905 of the 111,202,690 common shares outstanding, or 49.24%, were voted at the meeting. The results of the vote were reported to the meeting by Computershare, which acted as scrutineer at the meeting and were as follows: Director s Votes For % Votes Withheld % Paul Cataford 16,268,282 75.34 5,324,019 24.66 Anthony J. Giovinazzo
   Titan Medical Announces Executive Departure  2022/06/01 11:30:00 Kwhen Finance
   Medical Robots Market - Exclusive Report on Untapped Growth Opportunities and Megatrends | MDC Research Study  2022/04/08 11:45:11 Benzinga
Pune, April 08, 2022 (GLOBE NEWSWIRE) -- The global medical robots markets is driven by innovation and technological advancements which have played a vital role in contributing to the growth of this market. Due to innovation and technological advancements, patients are benefited in terms of shortened recovery time and reduced pain after surgery. Moreover, the companies are focusing on fund raising to strengthen the medical robots market for long run. However, safety concerns over robotic surgeries are likely to restrain the market. Medical Robots Market by Region The global medical robots market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of medical robots, followed by Europe and Asia Pacific. North America will continue to dominate the global medical robots market in the forecast period owing to factors such as increasing adoption of minimally invasive procedures, availability of wide range of treatment options, and technological advancements among others.
   Benzinga''s Top Ratings Upgrades, Downgrades For March 25, 2022  2022/03/25 14:02:44 Benzinga
Upgrades For Aris Water Solutions Inc (NYSE: ARIS ), Capital One upgraded the previous rating of Equal-Weight to Overweight. The stock has a 52-week-high of $19.16 and a 52-week-low of $10.06. At the end of the last trading period, Aris Water Solutions closed at $18.55. UBS upgraded the previous rating for Rio Tinto PLC (NYSE: RIO ) from Sell to Neutral. At the moment, the stock has a 52-week-high of $95.97 and a 52-week-low of $59.58. Rio Tinto closed at $78.30 at the end of the last trading period. For Farfetch Ltd (NYSE: FTCH ), Societe Generale upgraded the previous rating of Hold to Buy. For the fourth quarter, Farfetch had an EPS of $0.03, compared to year-ago quarter EPS of $0.06. At the moment, the stock has a 52-week-high of $59.00 and a 52-week-low of $10.75. Farfetch closed at $15.51 at the end of the last trading period. See all analyst ratings upgrades. Downgrades For AutoWeb Inc (NASDAQ: AUTO ), Lake Street downgraded the previous rating of Buy to Hold. For the fourth quarter, AutoWeb had an EPS of $0.20, compared to year-ago quarter EPS of $0.07.
   Titan Medical stock falls 6% amid FY21 results  2022/03/24 15:08:43 Seeking Alpha
Titan Medical''s <> stock fell following its FY21 results.For full year 2021, research and development expenses (R&D) rose to $37.9M, compared to $7.9M in 2020.The company…
   Titan Medical Inc. (TMDI) CEO Paul Cataford on Q4 2021 Results - Earnings Call Transcript  2022/03/24 14:18:03 Seeking Alpha
   Titan Medical reports FY results  2022/03/24 11:36:01 Seeking Alpha
Titan Medical press release (TMDI): reports cash and cash equivalents of $32.3M as of December 31.The company remains on track with activities to support a De Novo classification…